Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
WALNUT CREEK, Calif., Jan. 13, 2023 (GLOBE NEWSWIRE) -- Neurocentria, Inc., a privately held late-stage biotechnology company developing novel therapies for neurodegenerative and neuropsychiatric...
-
LODA, Ill., Jan. 11, 2023 (GLOBE NEWSWIRE) -- A private research group has secured a U.S. patent for a newly discovered vitamin. Vitamin MePiA is the second of two new vitamins that have been...
-
CHICAGO, Jan. 11, 2023 (GLOBE NEWSWIRE) -- AVANT, a platform for IT decision-making and the nation’s premier Technology Services Distributor, identified four ways channel partners can win new...
-
WATERTOWN, Mass., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation (TPD) to deliver novel...
-
ATLANTA, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Health care consulting leader Monument Analytics announces that it has changed its name to Stage Analytics™. The new name captures the importance of...
-
WATERTOWN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation (TPD) to deliver novel...
-
WATERTOWN, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small...
-
Golden, CO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- A new approach to manufacturing perovskite solar cells has addressed previous problems and yielded devices with high efficiency and excellent stability,...
-
KUTZTOWN, Pa., Dec. 20, 2022 (GLOBE NEWSWIRE) -- For more than 40 years, the Farming Systems Trial (FST) at Rodale Institute has combined real-world practices and rigorous scientific analysis to...
-
CARSON CITY, NV, Dec. 19, 2022 (GLOBE NEWSWIRE) -- CECORS, INC. (OTC PINK: CEOS) ("CeCors" or the "Company"), is pleased to announce that it has signed a binding letter of intent (LOI) with VetComm...